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Introduction {#sec005}
============

Attaining an accurate diagnosis remains one of the most challenging tasks with patients with Disorders of Consciousness (DOC) in the acute phase; an accurate diagnosis is crucial for prognosis validity because it influences medical management in terms of therapeutic choices and end-of-life decisions. Disorders of consciousness include a wide range of medical conditions in which patients present a global inability to interact with their environment in terms of wakefulness and awareness \[[@pone.0156882.ref001]\]. Among the broad nosology of DOC \[[@pone.0156882.ref002]\], three main ascending levels have been clinically identified according to behavioural criteria: Coma \[[@pone.0156882.ref003]\], Unresponsive Wakefulness Syndrome (UWS) \[[@pone.0156882.ref004]\], and a Minimally Conscious State (MCS) \[[@pone.0156882.ref005]\]. After an acute brain injury (BI), nearly 20% of patients suffer from DOC \[[@pone.0156882.ref006]\]; the majority of these patients fall into a coma, which is associated with a mortality rate of 40% within 6 hours in cases of traumatic BI (TBI) \[[@pone.0156882.ref007]\] and within 5 days in cases of non-traumatic BI (NTBI) \[[@pone.0156882.ref008]\]. Coma survivors then enter into a gradual process of consciousness recovery by evolving first into UWS and then into MCS until they emerge from DOC. However, the natural progression of recovery varies substantially across patients; between 10% \[[@pone.0156882.ref009], [@pone.0156882.ref010]\] and 30% \[[@pone.0156882.ref011]\] of coma survivors remain in UWS after four weeks. Moreover, the speed of recovery and the type of injury influence the level of recovery. Approximately 50% of patients experiencing UWS at least one month after BI remain in this state one-year after their TBI \[[@pone.0156882.ref009], [@pone.0156882.ref010], [@pone.0156882.ref012], [@pone.0156882.ref013]\]; this fraction increases to 85% post-NTBI \[[@pone.0156882.ref009], [@pone.0156882.ref010], [@pone.0156882.ref012]--[@pone.0156882.ref014]\]. With regard to the same time conditions, 23% \[[@pone.0156882.ref015], [@pone.0156882.ref016]\] and 43% of MCS \[[@pone.0156882.ref015]\] patients do not regain consciousness 12 months after TBI and NTBI, respectively.

Therefore, the most pressing clinical issue in the acute phase is to determine whether the diagnosis of these patients as being in UWS or MCS is correct and whether it is transient and a precursor of recovery. Although neuroimaging based on magnetic resonance imaging (MRI) or positron emission tomography \[[@pone.0156882.ref017]--[@pone.0156882.ref022]\] and neurophysiological studies \[[@pone.0156882.ref023]--[@pone.0156882.ref028]\] have led to major changes in the nosology of patients with DOC, the current standard for evaluating such states remains clinical examination. The JFK Coma Recovery Scale-Revised (CRS-R) \[[@pone.0156882.ref029]\] is currently the best instrument for DOC evaluation \[[@pone.0156882.ref030]\] \[[@pone.0156882.ref031]\]; this instrument seeks signs of conscious awareness using several subscales based on motor and verbal behaviour. Despite these advances in the nosology of DOC, the prevalence of misdiagnoses is as high as 43% in the post-acute and chronic phases \[[@pone.0156882.ref032]\] \[[@pone.0156882.ref033]\] and outcome predictability remains quite poor \[[@pone.0156882.ref030]\]. Further improvements in clinical assessment are accordingly necessary, especially when considered in the acute stage. Bias in diagnostic assessment in the acute phase may arise from erroneous quantification and interpretation of behavioural responses. Indeed, underlying motor, verbal or drive deficits \[[@pone.0156882.ref034]\] \[[@pone.0156882.ref035]\] may partially or completely inhibit intentional responses. Otherwise, the CRS-R scales require stringent criteria to define a certain level of consciousness, which in turn may lead to clinical underestimation of the content and amount of consciousness, if those criteria are not fulfilled. Therefore, exploring the broadest range of motor behavioural responses may result in a more accurate consciousness assessment that enables a more reliable outcome prediction. This longitudinal study presents the results of a combined CRS-R assessment with a new set of clinical tests measuring various motor signs in the acute phase.

Materials and Methods {#sec006}
=====================

Participants and study design {#sec007}
-----------------------------

We enrolled 33 patients (20 males and 13 females) among 65 patients who were admitted to our Unit of Acute Neuro-Rehabilitation (Department of Clinical Neurosciences at the University Hospital of Lausanne, Switzerland) between October 2011 and June 2014 for acute neuro-rehabilitation.

The inclusion criteria included a diagnosis of UWS or MCS (according to CRS-R criteria \[[@pone.0156882.ref029]\], supported by the Multi-Society Task Force Report \[[@pone.0156882.ref004]\] \[[@pone.0156882.ref036]\] and the Aspen criteria \[[@pone.0156882.ref005]\]) within 28 days of brain damage; we assumed a short cut-off time to avoid patients with prolonged DOC who might have biased the outcome assessment due to their lower probability of recovering \[[@pone.0156882.ref029], [@pone.0156882.ref037]\].

The exclusion criteria included a) current neuromuscular function blockers or sedation; b) a premorbid history of developmental, psychiatric or neurological illness resulting in documented functional disabilities at the time of damage; c) persistent acute illness or progressive systemic or neurological disease; d) fewer than three complete clinical assessments with the CRS-R throughout the study.

The first CRS-R evaluation was completed using our own set of clinical tests or observations referred to as the "Motor Behaviour Tool" (MBT), which will be described below.

We collected general patient information: Age, localisation of brain lesions from routine neuro-imaging, brain damage aetiology, total number of CRS-R performed, rehabilitation duration and delay between occurrence of brain lesion and the first CRS-R/MBT assessment, as between occurrence of brain lesion and the last CRS-R score.

All of the included patients received a standardised intensive programme of rehabilitation, including physical, occupational, neuropsychological and speech therapies totalling at least 3 hours per day.

The local Lausanne Ethics Committee approved this study (142--09) and the legal surrogates of all of the participants provided written informed consent.

Procedure {#sec008}
---------

We designed a two-stage procedure.

First, the enrolled patients underwent at least three successive CRS-R assessments with the aim of ensuring a weekly evaluation. The first assessment established the initial diagnosis of UWS or MCS \[[@pone.0156882.ref029]\] \[[@pone.0156882.ref030]\], and the following CRS-R scores determined the DOC outcome; motor (score = 6 of CRS-R subscale 3) or communication (score = 2 of CRS-R subscale 6) recovery defined emergence from DOC \[[@pone.0156882.ref029]\]. We divided the patients into two primary classes: Patients recovering consciousness with functional object use and/or functional communication (class 1) and patients remaining in DOC (class 2). We made the same subdivision for UWS and MCS, which led to six additional subclasses: (a) UWS and (b) MCS patients evolving to non-DOC, UWS patients (c) remaining in UWS or (d) evolving to MCS, and MCS patients (e) worsening to UWS or (f) remaining in MCS. We performed nine outcome comparisons: One global comparison between both main classes 1 and 2, and eight additional subclasses' comparisons encompassing four comparisons within the UWS patients and within the MCS patients, respectively. As a result, for the UWS patients, we compared subclass (a) with subclass (c), subclass (a) with subclass (d), subclass (c) with subclass (d), and subclass (a) with subclasses (c) and (d) together, which yielded a comparison between UWS patients emerging from DOC and those remaining in DOC. Likewise for the MCS patients, we compared subclass (b) with subclass (e), subclass (b) with subclass (f), subclass (e) with subclass (f), and subclass (b) with subclasses (e) and (f) together, which yielded a comparison between MCS patients emerging from DOC and those remaining in DOC. We analysed the first five CRS-R subscales because their scores defined the criteria for UWS and MCS, while the total score and the arousal subscore do not.

Second, we completed the CRS-R evaluation using the MBT evaluation, which was performed twice: At the first clinical evaluation with CRS-R, and two days later for confirmation. The CRS-R requires stringent response criteria for each subscore to assign a behavioural level and particularly to move from a low level of motor reflex behaviour (subscores 1--4) or absent verbal response (subscore 5) to the next level, which integrates the first clinical signs of consciousness. The application of stringent criteria means that insufficient but true signs of consciousness may not be quoted as an indication of consciousness, but rather as a reflex behaviour. Moreover, concomitant deficits or pathologies, including neuromyopathy, aphasia, or severe disorders of drive and motivation, additionally hamper motor or verbal responses \[[@pone.0156882.ref034]\]. Hence, both conditions lower the CRS-R score, leading to misdiagnoses of DOC.

We designed the MBT to complement the description of limb, facial, ocular and oral motricity, and verbal behaviour. This tool consists of a set of 10 clinical items that explore different positive motor signs (items 1 to 5) that the CRS-R scheme may overlook, medical conditions (items 6 and 7) that may hide conscious signs (negative signs) and various reflex responses (items 8--10) ([Table 1](#pone.0156882.t001){ref-type="table"}). The kinematics of non-reflex or intentional movement were defined in opposition to the kinematics of spinal motor reflexes and the nociceptive withdrawal reflexes triggered at rest; for example, the maximal elicitation of the mechanical reflex response in the upper limb due to a nociceptive stimulation applied on the index finger, consists of wrist adduction (frontal plane), elbow flexion (sagittal plane), and shoulder anteflexion (sagittal plane) occurring in two planes \[[@pone.0156882.ref038]\]. The first item looks for any limb movement whose kinematics differ from the motor reflex response in terms of orientation planes and the type of elicited muscles; such movements may be spontaneous or induced by a sensitive stimulation. The second item explores any isolated ocular movements that may be related to a hint of fixation or pursuit. The third item looks for hints of isolated intentional movements elicited by verbal command; reproducibility is typically lacking due to concomitant disorders, such as perseveration or drive disorders. The fourth item looks for any hint of a grimace induced by a noxious stimulus. The fifth item explores any motor behaviour that can be enhanced by a motivational context, such hearing a familiar voices or engaging in outdoor therapy. The sixth and seventh items take into account concomitant pathologies, including cranial nerve palsy, myopathies, and severe disorders of drive, which may hide facial motion or vocalisation, respectively. The last three items looks for increased motor reflexes triggered by simple stimulation (limb and oral, items 8 and 10 respectively) and for roving eyes.

10.1371/journal.pone.0156882.t001

###### Description of the items of the Motor Behavioural Tool.
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       MOTOR BEHAVIOUR TOOL (MBT)                                                                                                                                                                                                                                                                                                Yes   No
  ---- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- ----
  1    Observation of non-reflex movements (hypokinetic, spontaneous, or induced by a sensitive or a nociceptive stimulus)                                                                                                                                                                                                             
  2    Observation of isolated ocular movements (fixation with low reproducibility, pursuit with signs of perseveration)                                                                                                                                                                                                               
  3    Presence of intentional movements to command but with low reproducibility (due to signs of perseveration, to disorders of attention or to aphasia)                                                                                                                                                                              
  4    Observation of facial movement in response to noxious stimulation                                                                                                                                                                                                                                                               
  5    Observation of increased motor behaviours in a motivational context (familiar voices, outdoor therapy, enjoyable stimulation)                                                                                                                                                                                                   
  6    Facial akinasia in the context of concomitant causal pathologies (cranial nerve palsy, cranial or peripheral neuromyopathies, and disorders of drive and motivation linked with strategic lesions based on neuroimaging or on electromyographic data)                                                                           
  7    In case of extubation or tracheostomy with speaking valve: absence of vocalization in the context of concomitant causal pathology (cranial nerve palsy, cranial or peripheral neuromyopathies, and disorders of drive and motivation, linked with strategic lesions based on neuroimaging or on electromyographic data)         
  8    Abnormal motor or neurovegetative reflex induced by stimulation                                                                                                                                                                                                                                                                 
  9    Signs of roving eyes or absence of oculocephalic reflex                                                                                                                                                                                                                                                                         
  10   Increased oral reflex                                                                                                                                                                                                                                                                                                           

The MBT uses a non-cumulative binary scoring system with 1 and 0 indicating the presence or absence of a clinical item, respectively. Since the MBT complements CRS-R measurements, we expected the MBT to weight positively the score of the first five CRS-R subscales, when the latter are quoted at the reflex level for the motor responses (scores 1, 1, 2, and 1 for the auditory, visual, motor, and oromotor functions, respectively) and at 0 (none) for the communication function. When at least one positive MBT sign (items 1--5) is present, the principle is to increment progressively (step of 0.1) the value of the CRS-R subscale when quoted at the reflex level, until attaining the next score that highlights the first clinical signs of consciousness. For example, if the visual function scale is set to the reflex level of 1, then this value is progressively increased (1.1, 1.2, 1.3,..., 1.9) when the first positive MBT sign is observed. We hypothesise that MBT items 1, 3 and 5 increase all five CRS-R subscales; item 2 increases the auditory and visual function scales, and item 4 increases the oromotor and motor function scales ([Table 2](#pone.0156882.t002){ref-type="table"}). We performed statistical analysis on each increment to identify the critical point discriminating the different outcome of classes and subclasses.

10.1371/journal.pone.0156882.t002

###### Increase of the CRS-R subscores in presence of at least one positive MBT item.
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                   Auditory function scale            Visual function scale           Motor function scale                  Oromotor function scale      Communication scale
  ---------------- ---------------------------------- ------------------------------- ------------------------------------- ---------------------------- -----------------------------
  6                                                                                   Functional object use                                              
  5                                                   Object recognition              Automatic motor response                                           
  4                Consistent movement to command     Object localization: reaching   Object manipulation                                                
  3                Reproducible movement to command   Pursuit eye movements           Localization to noxious stimulation   Intelligible verbalization   
  CRS-R Increase                                                                      ⇧                                                                  
                                                                                      MBT items 1-3-4-5                                                  
  2                Localization to sound              Fixation                        Flexion withdrawal                    Vocalization/oral movement   Functional: accurate
  CRS-R Increase   ⇧                                  ⇧                                                                     ⇧                            
                   MBT items 1-2-3-5                  MBT items 1-2-3-5                                                     MBT items 1-3-4-5            
  1                Auditory startle                   Visual startle                  Abnormal posturing                    Oral reflexive movement      Non-functional: intentional
  CRS-R Increase                                                                                                                                         ⇧
                                                                                                                                                         MBT items 1-3-5
  0                None                               None                            None/flaccid                          None                         None

Two members of our research team, which includes a physician, a neuropsychologist, and a nurse, conducted the CRS-R and MBT assessment using video recordings.

Since patients share the same kind of structural brain lesions with different DOCs, or present different lesion localisations within the same consciousness disorder, structural MRI cannot differentiate states of consciousness \[[@pone.0156882.ref017]\]. We performed MRI morphometric analysis on our data to confirm this statement.

Statistical analysis {#sec009}
--------------------

We performed three methodological steps in our statistical analysis.

The first step consisted of analysing the CRS-R data. First, we performed the statistical prediction of DOC outcome using the first CRS-R subscores. Our statistical testing was based on a non-parametric Mann-Whitney U test because of the multinomial distribution of the CRS-R data. Second, since the CRS-R assessments were made across patients at different time points and with variable frequencies, we fit the longitudinal CRS-R data of each patient with a Generalised Linear Model (GLM) to obtain valuable temporal information regarding the DOC evolution of all classes/subclasses. The model regressors for the GLM consisted of four polynomials with progressive degrees ranging from 0--3 (constant, linear, quadratic and cubic polynomials) defining a polynomial regression model in one variable, referred to as a cubic model. We orthogonalised the polynomials such that the measured CRS-R variable could be projected into a canonical space spanned by the regressors. We then used the polynomial regressors according to a combinatorial process. As a normality test, we adopted the Lilliefors test \[[@pone.0156882.ref039]\], which revealed that the calculated regression coefficients followed a Gaussian distribution. We applied a one-sample two-tailed *t*-test on the regression coefficients, and then we calculated the temporal mean curve with its standard error for each class and subclass.

In the second step, we statistically predicted the DOC outcome from the MBT values also using a non-parametric Mann-Whitney U test because of the Bernoulli distribution of the binary MBT data. We computed sensitivity, specificity, and Yule's Q coefficient to test the performance of the statistical comparison.

The third statistical step consisted of assessing the outcome prediction on each increment of the CRS-R subscores enhanced by the MBT to identify a possible critical point discriminating the DOC outcome. The multinomial distribution of the CRS-R scores justified the application of a non-parametric Mann-Whitney U test.

Our study focused on a primary endpoint---the recovery prediction from DOC at discharge from our unit---and a secondary endpoint---the combined endpoint referring to functional walking ability and the likelihood of returning home.

We performed all of the statistical comparisons for each step between classes 1 (patients recovering consciousness with functional object use and/or functional communication) and 2 (patients remaining in DOC) and between the following subclasses: UWS patients evolving to non-DOC compared with UWS patients remaining in UWS and/or evolving to MCS; MCS patients evolving to non-DOC compared with MCS patients worsening to UWS and/or remaining in MCS. We applied the Bonferroni-Holm multiple comparison procedure to control the family-wise error rate. We performed the statistical testing in Matlab 12.0 (MathWorks, Natick, Massachusetts, USA).

To assess the anatomical differences between classes 1 and 2, we performed MRI voxel-based morphometry (VBM) \[[@pone.0156882.ref040]\] using the fast diffeomorphic image registration algorithm \[[@pone.0156882.ref041]\] and the statistical approach of statistical parametric mapping (SPM) (<http://www.fil.ion.ucl.ac.uk/spm/>).

For multiple comparisons correction, we applied a false discovery rate (FDR) control method in VBM. We used Matlab 12.0 for the algorithm implementation of statistical testing and SPM.

Results {#sec010}
=======

In [Table 3](#pone.0156882.t003){ref-type="table"}, we present detailed information about individual patient demographics (i.e., age, localization of brain lesions, BI aetiology, total number of CRS-R performed until discharge from the unit, rehabilitation duration and the delay between the occurrence of brain lesions and the first CRS-R/MBT assessment, as between the occurrence of brain lesions and the last CRS-R score).

10.1371/journal.pone.0156882.t003

###### Information about individual patient demographics.

CRS-R: Coma Recovery Scale-Revised; DOC: disorders of consciousness; UWS: unresponsive wakefulness syndrome; MCS: minimally conscious state; TBI: traumatic brain injury; IS: ischemic stroke; HS: haemorrhagic stroke; RA: ruptured aneurysm; IVH: intra-ventricular haemorrhage; DAI: diffuse axonal injury; F: frontal; T: temporal; P: parietal; O: occipital; BG: basal ganglia;Mes: mesencephalon; r: right; l: left; b: bilateral.
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  Patient No.   Age (years)   Diagnosis   Brain lesion localisation   Etiology   Delay insult first CRS-R (days)   Numbers of CRS-R   Delay insult---last CRS-R (days)   Rehabilitation duration (days)   Outcome   Return home   Walk
  ------------- ------------- ----------- --------------------------- ---------- --------------------------------- ------------------ ---------------------------------- -------------------------------- --------- ------------- ------
  1             20            UWS         bF, rT, rP, rBG             TBI        19                                4                  54                                 21                               Non DOC   Yes           Yes
  2             76            UWS         rP, rO                      IS         15                                4                  70                                 59                               Non DOC   No            No
  3             51            MCS         lF, bT, bP                  TBI        5                                 3                  41                                 16                               MCS       No            Yes
  4             57            UWS         rF, rT                      HS (RA)    27                                4                  61                                 21                               MCS       Yes           Yes
  5             48            MCS         Pons                        HS         9                                 3                  94                                 55                               Non DOC   No            No
  6             25            MCS         rF, bT, rP                  TBI        13                                3                  94                                 7                                Non DOC   Yes           Yes
  7             53            MCS         bT, lP                      TBI        9                                 4                  25                                 19                               Non DOC   Yes           Yes
  8             67            UWS         lF, lP, rO                  IS (RA)    18                                4                  41                                 48                               Non DOC   Yes           Yes
  9             53            MCS         rBG                         Inf        12                                6                  98                                 21                               Non DOC   Yes           Yes
  10            41            UWS         rF, rT, rP, rBG             HS         5                                 7                  34                                 20                               Non DOC   No            No
  11            24            UWS         bF, lBG, DAI                TBI        9                                 7                  52                                 35                               MCS       Yes           No
  12            65            MCS         lBG                         Inf        12                                6                  60                                 33                               MCS       NA            NA
  13            68            MCS         lF, lP                      HS         6                                 3                  39                                 37                               Non DOC   No            No
  14            65            MCS         bF                          TBI, IS    7                                 3                  26                                 14                               Non DOC   Yes           Yes
  15            18            UWS         bF, bT, lBG, Mes            TBI        15                                6                  69                                 41                               MCS       Yes           Yes
  16            55            UWS         rT, rP                      HS         14                                3                  54                                 20                               Non DOC   Yes           Yes
  17            24            MCS         rT                          TBI        4                                 3                  26                                 8                                Non DOC   Yes           Yes
  18            73            UWS         Pons                        IS, IVH    7                                 9                  56                                 43                               Non DOC   Yes           NA
  19            68            UWS         bF                          TBI        2                                 3                  24                                 15                               Non DOC   Yes           Yes
  20            37            UWS         bF, bT, bP, bO, bBG         Anoxia     8                                 8                  65                                 24                               UWS       No            No
  21            35            UWS         bF, bT, lP                  TBI        18                                7                  59                                 33                               UWS       No            No
  22            49            UWS         bBG, Mes, Pons              IS         27                                6                  65                                 42                               MCS       No            No
  23            20            MCS         bF, bT, bP, DAI             TBI        7                                 3                  33                                 13                               Non DOC   Yes           Yes
  24            66            MCS         bT                          TBI        9                                 3                  25                                 13                               Non DOC   Yes           Yes
  25            24            UWS         bBG, Mes, Pons              TBI (PO    5                                 9                  48                                 36                               MCS       No            No
  26            59            UWS         bF                          TBI        11                                3                  31                                 14                               Non DOC   Yes           Yes
  27            22            UWS         lF, lT, lP                  TBI        11                                8                  31                                 8                                UWS       No            No
  28            53            UWS         rF, rT                      HS (RA)    8                                 9                  64                                 41                               UWS       No            No
  29            63            UWS         bF, bP                      IS (RA)    18                                10                 71                                 48                               Non DOC   Yes           Yes
  30            62            UWS         rF, rT, bP, bO              TBI (Op)   5                                 9                  75                                 33                               Non DOC   Yes           No
  31            55            MCS         bF, bP, bBG                 HS         1                                 7                  53                                 36                               Non DOC   Yes           Yes
  32            42            UWS         lBG, DAI                    TBI        16                                5                  40                                 22                               Non DOC   Yes           Yes
  33            43            MCS         lF, bBG, Mes                IS         17                                3                  44                                 19                               MCS       NA            NA

For 31 of the enrolled patients, the CRS-R evaluation could be performed weekly (mean interval between evaluations: 7.5 ± 2.9 days), which yielded a significant correlation between the number of CRS-R evaluations and the duration of patient care (correlation coefficient of 0.59 with p = 0.0005). Patients 5 and 6 could not be followed weekly, but they were still selected for the study since they satisfied the eligibility criteria. Our general results comparing classes 1 and 2 for each aforementioned characteristic are listed in [Table 4](#pone.0156882.t004){ref-type="table"}. General patient information was matched for both classes 1 and 2 (p\>0.05), particularly in terms of brain lesion localisation, brain damage aetiology, the number of CRS-R evaluations, the delay between the occurrence of brain lesions and first CRS-R/MBT assessment, and the delay between the occurrence of brain lesions and the last CRS-R assessment.

10.1371/journal.pone.0156882.t004

###### Statistical characteristics of the patients emerging from DOC compared to the patients remaining in DOC.

P-values corrected for multiple comparison with the Holm-Bonferroni method. ° statistical comparison between UWS patients and MCS patients having emerged from DOC, respectively. DOC: disorders of consciousness; UWS: unresponsive wakefulness syndrome; MCS: minimally conscious state; SD: standard deviation.
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                                                    Remaining in DOC   Emerging from DOC   p-value corrected
  ------------------------------------------------- ------------------ ------------------- -------------------
  **DOC (n = 33)**                                  12 (36%)           21 (64%)            
  ** UWS (n = 20, 61%)**                            5 (25%) in UWS     11 (55%)            \>0.05°
                                                    4 (20%) in MCS                         
  ** MCS (n = 13, 39%)**                            3 (23%) in MCS     10 (77%)            
                                                    0 (0%) in UWS                          
  **Age (years)**                                   39.83 (15.5)       52.52 (17.6)        \>0.05
  **Number of CRS**                                 6.33 (2.1)         4.71 (2.33)         \>0.05
  **Delay brain injury---first CRS-R/MBT (days)**   13.5 (7.6)         9.85 (5.3)          \>0.05
  **Delay brain injury---last CRS-R (days)**        54.91 (11.7)       50.62 (24.5)        \>0.05
  **Rehabilitation duration (days)**                29.08 (11.2)       26.95 (15.9)        \>0.05
  **Lesion localization**                                                                  \>0.05
  ** Frontal**                                      9 (75%)            12 (57%)            
  ** Temporal**                                     7 (58%)            9 (43%)             
  ** Parietal**                                     4 (33%)            12 (57%)            
  ** Occipital**                                    1 (8%)             3 (14%)             
  ** Basal Ganglia**                                7 (58%)            5 (24%)             
  ** Midbrain**                                     4 (33%)            2 (10%)             
  ** Diffuse axonal injury**                        1 (8%)             2 (10%)             
  **Etiology**                                                                             \>0.05
  ** Ischemic stroke**                              3 (25%)            5 (24%)             
  ** Hemorrhagic stroke**                           0                  5 (24%)             
  ** Intraventricular hemorrhage**                  0                  1 (5%)              
  ** Traumatic brain injury**                       5 (42%)            10 (48%)            
  ** Ruptured aneurism**                            2 (17%)            2 (10%)             
  ** Anoxia**                                       2 (8.3%)           0                   
  ** Infection**                                    2 (8.3%)           1 (5%)              
  ** Other vascular disease**                       2 (8.3%)           1 (5%)              
  **Secondary endpoint**                                                                   
  ** Functional walking ability**                   3 (25%)            15 (70%)            0.021
  ** Return home**                                  3 (25%)            17 (81%)            0.007

Among the 33 enrolled patients, 20 patients (61%) were diagnosed as being in UWS, and 13 patients (39%) were diagnosed as being in a MCS at the first evaluation. Globally, 21 patients (64%) recovered consciousness (class 1); 12 patients (36%) remained with DOC (class 2). Specifically, 11 out of 20 UWS patients (55%) emerged from DOC (subclass (a)); among the UWS patients still in DOC (45%), 4 patients (20%) remained in UWS (subclass (c)) and 5 patients (25%) evolved to MCS (subclass (d)); among the MCS patients, 10 out of 13 patients (77%) emerged from DOC (subclass (b)), 3 patients (23%) remained in MCS (subclass (f)), and no patients worsened to UWS (subclass (e)). Although our outcome comparison between UWS and MCS patients was not statistically significant (p\>0.05), the absolute values tended to be largely consistent with the data appearing in the literature \[[@pone.0156882.ref009], [@pone.0156882.ref015], [@pone.0156882.ref016]\]. However, there was no significant difference between TBI and NTBI, while recovery is expected to be more favourable in TBI \[[@pone.0156882.ref012], [@pone.0156882.ref014], [@pone.0156882.ref015]\]. Finally, the difference was significant for returning home (p = 0.007) and walking ability (p = 0.021).

Among the nine comparison analyses performed within each statistical step, four outcome comparisons exhibited significant differences and are discussed in detail below. Therefore, the results of the following subclasses' comparisons are not discussed: For the UWS patients, both comparisons between subclass (d) and subclasses (a) or (d) because of their insignificant differences, and the three comparisons involving subclass (e) since no MCS patients worsened to UWS.

First, a statistical comparison of the first CRS-R subscales did not permit us to differentiate between the patients recovering consciousness (class 1) from those patients remaining with DOC (class 2) ([Table 5](#pone.0156882.t005){ref-type="table"}). In the GLM analysis of the longitudinal CRS-R subscales, only combined together no-order (baseline) and first-order (slope) polynomial parameters, which outline the linear time course of the data, exhibited significant differences (p\<0.02) when compared between both classes 1 and 2, between UWS subclass (a) and UWS subclasses (c) and (d) together, and between both MCS subclasses (b) and (f). Additionally, those time course differences yielded the following information: Temporal discrimination was not possible within the first 19 days for all subscales and the cut-off scores for the diagnosis of consciousness recovery were attained after 29 days for the motor function subscale and after 40 days for the communication subscale ([Fig 1](#pone.0156882.g001){ref-type="fig"}).

![Fitting of the longitudinal CRS-R using the General Linear Modelling.\
GLM fitting of the longitudinal CRS-R subscales data; outcome differentiation over time for each subscale between patient emerging from DOC (in blue) and those remaining in DOC (in red); solid lines represent the mean of the time evolution and dash lines represent the superior and inferior bounds of the standard error of the means. Abscissa axe from top to bottom: auditory function scale, visual function scale, motor function scale, oro-motor function scale, communication scale; ordinate axe from left to right: DOC, UWS, MCS. Group distinction not earlier than 19 days according to the various subscales: 20 days for the auditory subscale for all groups of patients; 21 days for the visual subscale; between 19 and 21 days for the motor subscale; between 21 and 22 days for the oro-motor subscale; between 22 and 23 days for the communication subscale. Cut-off scores for the diagnosis of consciousness recovery reached after at least 29 days for the motor function subscale and after at least 40 days for the communication subscale. GLM: General Linear modelling; CRS-R: Coma Recovery Scale-Revised; DOC: disorders of consciousness; UWS: unresponsive wakefulness syndrome; MCS: minimally conscious state.](pone.0156882.g001){#pone.0156882.g001}

10.1371/journal.pone.0156882.t005

###### Statistical prediction of the outcome from the CRS-R scores alone and weighted by the MBT scores (p-values corrected).

Statistical prediction of the outcome from the first CRS-R subscores (auditory, visual, motor and oro-motor functions, and communication subscales) and from the same CRS-R subscores weighted by the MBT clinical values, assessed in the acute phase (mean 11.2 days after brain damage). Prediction proceeded for DOC classes, and for UWS and MCS subclasses. P-values corrected for multiple comparison with the Holm-Bonferroni method. CRS-R: Coma Recovery Scale-Revised; DOC: disorders of consciousness; UWS: unresponsive wakefulness syndrome; MCS: minimally conscious state; MBT: Motor Behavioural Tool.
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                                                  Auditory function subscale            Visual function subscale            Motor function subscale            Oro-motor function subscale            Communication subscale   
  ----------------------------------------------- ---------------------------- -------- -------------------------- -------- ------------------------- -------- ----------------------------- -------- ------------------------ --------
  **Remaining in DOC vs Emerging from DOC**       \>0.05                       0.008    \>0.05                     0.018    \>0.05                    0.018    \>0.05                        0.002    \>0.05                   0.002
  **Remaining in UWS/MCS vs Emerging from DOC**   \>0.05                       0.007    \>0.05                     0.009    \>0.05                    0.004    \>0.05                        0.008    \>0.05                   0.009
  **Remaining in UWS vs Emerging from DOC**       \>0.05                       0.007    \>0.05                     0.004    \>0.05                    0.007    \>0.05                        0.006    \>0.05                   0.003
  **Remaining in MCS vs Emerging from DOC**       \>0.05                       \>0.05   \>0.05                     \>0.05   \>0.05                    \>0.05   \>0.05                        \>0.05   \>0.05                   \>0.05

Second, a statistical comparison on the MBT values revealed that all positive (items 1--5) and negative (items 6 and 7) MBT signs yielded a significant predictive value for discriminating between classes 1 and 2; an exception was observed for item 7 in the comparison of both classes 1 and 2 (p\>0.05). We also observed the same results for UWS patients when we compared subclass (a) with subclass (c), and with subclasses (c) and (d) together. Moreover, the three reflexes items (MBT 8--10) also presented predictive properties for overall DOC patients (a comparison of classes 1 and 2) and UWS patients (subclass (a) compared with subclasses (c) and (d) together). On the other hand, comparisons of other subclasses (comparison between the (b) and (f) MCS subclasses and between (a) and (d), and the (c) and (d) UWS subclasses) did not reveal statistically significant differences. The statistical comparison was characterised by elevated sensitivity, specificity, and Yule's Q coefficient. Some sensitivity values were equal to 1, which was incompatible with the expected Bayes error rate (minimum error bound); this finding may be explained by the small sample size of some subclasses. The results are detailed in [Table 6](#pone.0156882.t006){ref-type="table"}.

10.1371/journal.pone.0156882.t006

###### Statistical prediction of the outcome from the MBT scores.

Statistical prediction of the outcome from the clinical values of the MBT items, assessed in the acute phase at first CRS-R evaluation (mean 11.2 days after brain damage). Prediction proceeded for DOC classes, and UWS and MCS subclasses. Indices of the MBT items refer to the MBT indices presented in [Table 1](#pone.0156882.t001){ref-type="table"}. P-values corrected for multiple comparison with the Holm-Bonferroni method. Sensitivity, specificity and Yule's Q coefficient not assessed when p-values \>.05 of the non-parametric Mann-Whitney U test. DOC: disorders of consciousness; UWS: unresponsive wakefulness syndrome; MCS: minimally conscious state; MBT: Motor Behavioural Tool.
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                                                     MBT 1    MBT 2    MBT 3    MBT 4    MBT 5    MBT 6    MBT 7    MBT 8    MBT 9    MBT 10
  -------------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  **Remaining in DOC vs Emerging from DOC**                                                                                           
   p-value (corr)                                    0.013    0.012    0.005    0.005    0.011    0.013    0.053    0.005    0.039    0.004
   Sensitivity                                       0.86     0.81     0.90     \<1      0.90     0.86     0.76     0.5      0.25     0.5
   Specificity                                       0.67     0.75     0.67     0.5      0.58     0.67     0.58     \<1      \<1      \<1
   Yule\'s Q coef                                    0.91     0.91     0.92     0.91     0.9      0.91     0.84     0.91     0.75     0.91
  **Remaining in UWS or MCS vs Emerging from DOC**                                                                                    
   p-value (corr)                                    0.019    0.016    0.019    0.017    0.03     0.015    0.03     0.03     0.04     0.03
   Sensitivity                                       \<1      0.91     \<1      \<1      0.91     \<1      0.91     0.56     0.33     0.56
   Specificity                                       0.67     0.78     0.67     0.67     0.67     0.67     0.67     \<1      \<1      \<1
   Yule\'s Q coef                                    0.91     0.92     0.91     0.91     0.88     0.91     0.88     0.86     0.69     0.86
  **Remaining in MCS vs Emerging from DOC**                                                                                           
   p-value (corr)                                    \>0.05   \>0.05   \>0.05   \>0.05   \>0.05   \>0.05   \>0.05   \>0.05   \>0.05   \>0.05
   Sensitivity                                       ---      ---      ---      ---      ---      ---      ---      ---      ---      ---
   Specificity                                       ---      ---      ---      ---      ---      ---      ---      ---      ---      ---
   Yule\'s Q coef                                    ---      ---      ---      ---      ---      ---      ---      ---      ---      ---

Third, a statistical comparison of CRS-R subscales weighted by the positive MBT signs allowed those subscales to become predictive for overall DOC outcome (class 1 compared with class 2) and for UWS patients ((a) subclass compared with (c) subclass, and with the (c) and (d) subclasses). Even if they had a low increment (0.5), all of the items of the positive MBT signs were particularly valuable for enriching all of the CRS-R subscales (p\<0.019). On the other hand, differences between MCS subclasses (b) and (f), between UWS subclasses (a) and (d), and between UWS subclasses (c) and (d), were not statistically significant ([Table 5](#pone.0156882.t005){ref-type="table"}).

The absence of significant differences between the MCS subclass compared with either the UWS subclass or with the non-DOC subclass can be explained by the small sample size and additionally by the closeness of the CRS-R subscores between these states.

Finally, VBM of brain lesions did not reveal any significant anatomical differences between classes 1 and 2 (p\>0.05).

Discussion {#sec011}
==========

In this study, we systematically evaluated acute DOC patients using the CRS-R scheme and of our MBT; the latter has been designed to identify clinical signs of consciousness that the CRS-R scheme may overlook, thereby leading to DOC misdiagnoses by lowering the CRS-R score.

We present three primary findings:

1.  A statistical comparison applied to the first CRS-R evaluation in the acute stage did not yield predictable properties, meaning that an accurate diagnosis and prognosis cannot be reliably attained during this critical period using only CRS-R scores. However, regression modelling on the CRS-R subscales enabled us to differentiate over time the patients remaining with DOC from those having emerged from DOC, but the outcome discrimination was not significant in the first 19--22 days, regardless of the CRS-R subscores. Moreover, we found that at least 29 days is required to attain the cut-off scores for the diagnosis of consciousness recovery given by the motor function and the communication subscales. Our data corroborate the understanding that the prognostic validity of the CRS-R remains unproven in the acute phase \[[@pone.0156882.ref030]\] \[[@pone.0156882.ref033]\] despite its good content validity \[[@pone.0156882.ref030]\] and its recommendation as a tool for establishing diagnosis and monitoring recovery of consciousness \[[@pone.0156882.ref031]\].

2.  Our statistical comparison revealed that the positive items of the MBT help to better identify signs of consciousness and provide reliable predictability addressing consciousness recovery. All of those items check for slight motor activities, which are by definition overlooked by the CRS-R, which imposes strong criteria to consider a motor behaviour as the expression of consciousness. Concretely, the CRS-R does not support non-systematised hypokinetic movement, hieratic oculomotricity, the draft of intentional motor responses, and slight induced facial motricity by noxious stimulus or increased motor behaviour due to a motivational context. This leads to negative scoring, whereas such motor features may express a conscious activity, especially since concomitant motor or cognitive impairment hamper motricity \[[@pone.0156882.ref034]\]. The two negative MBT items also share predictive properties, in the sense of enlightening concomitant medical conditions, which offer a credible alternative to the explanation of impaired verbal or motor response. Finally, the presence of reflex behaviours speaks for increased consciousness impairment and poorer outcomes.

3.  With regard to the reliable predictability of the positive MBT items, it became apparent that their introduction into the CRS-R assessment rendered the CRS-R subscores also significantly predictable, meaning that strong quoting rules do disservice to clinical evaluations of consciousness.

These results lead to two primary potentialities that should be discussed.

First, motor behaviour evaluation in the acute phase is a main way to accurately assess the content and the degree of consciousness and to predict outcome within the first 6 weeks. The fact that subtle motor behaviour can promote the predictability of DOC outcome, whereas the CRS-R subscores cannot, highlights the importance of exploring and considering all levels of motor activity that can reveal preserved consciousness. As a result, the CRS-R remains a valuable scheme that should be adapted to refine grading stages. With this finding in mind, additional studies should emphasise the performance analysis of all sub-items included in all the available evaluation schemes.

Second, our findings provide significant evidence that a reliable measure of conscious awareness in the acute phase necessarily needs to take into account the patient\'s capacity to perceive, understand and interact with his environment, his awareness of himself and his reaction to pain. Developed from evaluations starting as early as 24 hours after sedation withdrawal, MBT emphasises the observation of the broadest levels of subtle motor signs that may be seen as non-reflexive intentional responses in opposition to reflexive motor reaction; additionally, MBT takes into consideration concomitant medical conditions, such motor or communication disabilities, that hamper the patient\'s interaction with his environment \[[@pone.0156882.ref042]\]. The significant outcome prediction for both positive and negative MBT items, in terms of consciousness recovery and improvements in walking skills, may highlight the involvement of blocked motor efference rather than a true consciousness disorder. Patients presenting the \"trap\" of blocked motor efference might demonstrate the clinical signs of a new nosological entity: Cognitive motor dissociation \[[@pone.0156882.ref043]\], a condition in which "a lack of purposeful motor behaviour" hides motor response due to an underlying structural disruption between the motor cortex and the thalamus \[[@pone.0156882.ref044]\]. This condition leads to consciousness impairment overestimation, while the degree and level of consciousness are largely preserved. Establishing that a patient has such a neurological condition is of great significance with regard to therapeutic choices and global medical management because of a much better prognosis.

Additional improvements to MBT might investigate case-specific questions and address each patient individually by varying the testing conditions. Moreover, advances in neuroimaging technologies and the integration of electrophysiological paradigms into a reliable communication tool \[[@pone.0156882.ref045]\] might provide additional indications of awareness signs that ultimately lead to reducing the incidence of misdiagnoses and ensuring better treatment.

Conclusion {#sec012}
==========

The identification and classification of enlarged motor behaviour, without restrictions on their characteristics and the localisation of lesions along with their expected related symptoms, should be systematically considered to overcome the aforementioned limits of the existing scales. Such work would improve diagnostic and prognostic knowledge in DOC care in the acute phase.
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